The results are similar for IDH2 mutated AML, RUNX1 mutated AML and AML with myelodysplasia related (MR) gene mutations, depending on the absence or presence of an activated kinase pathogenic variant (51). This evidence concerns the gene RUNX1 and acute myeloid leukemia.